©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2007; 13(40): 5351-5356
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5351
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5351
Table 3 Perioperative risk factors for pancreatic fistula
| Pancreatic fistula (+)(n = 24) | P value | |
| Age (yr) | 62.3 ± 10.2 | 0.565 |
| Male:Female | 2:1 | 0.582 |
| Preoperative disease | ||
| Diabetes mellitus | 4 (7%, 4/54) | 0.959 |
| Laboratory findings | ||
| Hypoalbuminemia (3 < g/dL) | 3 (9%, 3/33) | 0.729 |
| Hyperbilirubinemia (> 2 mg/dL) | 14 (7%, 14/195) | 0.665 |
| Pathologic feature | 0.039 | |
| Ampulla of Vater cancer | 4 (5%, 4/80) | |
| Common bile duct cancer | 13 (16%, 13/84) | |
| Pancreatic cancer | 4 (4%, 4/91) | |
| Duodenal cancer | 0 (0%, 0/12) | |
| Others | 3 (8%, 3/36) | |
| Type of resection | 0.097 | |
| PPPD | 22 (10%, 22/218) | |
| Whipple's op. | 2 (2%, 2/85) | |
| Outer layer suture method | 0.102 | |
| Interrupted | 14 (11%, 14/133) | |
| Continuous | 10 (6%, 10/170) | |
| Pancreas consistency | < 0.001 | |
| Hard | 2 (2%, 2/87) | |
| Firm | 11 (7%, 11/162) | |
| Soft | 11 (20%, 11/54) | |
| Total operative time (min) | 383 ± 52 | 0.515 |
| Estimated blood loss (mL) | 564 ± 220 | 0.831 |
| Use of prophylactic Octreotide | 14 (7%, 14/205) | 0.317 |
| Lymph node metastasis | 0.351 | |
| Yes | 17 (9%, 17/197) | |
| No | 7 (7%, 7/106) | |
| Positive resection margin | 0.105 | |
| Yes | 1 (4%, 1/26) | |
| No | 23 (8%, 23/277) |
-
Citation: Lee SE, Yang SH, Jang JY, Kim SW. Pancreatic fistula after pancreaticoduodenectomy: A comparison between the two pancreaticojejunostomy methods for approximating the pancreatic parenchyma to the jejunal seromuscular layer: Interrupted
vs continuous stitches. World J Gastroenterol 2007; 13(40): 5351-5356 - URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5351.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i40.5351